vimarsana.com

Page 3 - பிரீட்ரிச் ஷில்லர் பல்கலைக்கழகம் ஜீனா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Making the invisible visible

Researchers from University Jena, the University of California Berkeley and the Institut Polytechnique de Paris use intense laser light in the XUV spectrum to generate second harmonics on a laboratory scale. As the team writes in Science Advances, they were able to achieve this effect for the first time with a laser source on a laboratory scale and thus investigate the surface of a titanium sample down to the atomic level.

Tolkien as a Literary Artist - Exploring Rhetoric, Language and Style in The Lord of the Rings | Thomas Kullmann

Tolkien as a Literary Artist ISBN 978-3-030-69299-5 Hardcover $149.99 price for USA Customers within the U.S. and Canada please contact Customer Service at +1-800-777-4643, Latin America please contact us at +1-212-460-1500 (24 hours a day, 7 days a week). Pre-ordered printed titles are excluded from promotions. Due: June 6, 2021 ISBN 978-3-030-69298-8 Institutional customers should get in touch with their account manager This book takes a fresh look at Tolkien’s literary artistry from the points of view of both linguistics and literary history, with the aim of shedding light on the literary techniques used in

mediacongo net - Actualités - Appel à une enquête complète sur les origines du Covid-19

mediacongo net - Actualités - Appel à une enquête complète sur les origines du Covid-19
mediacongo.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mediacongo.net Daily Mail and Mail on Sunday newspapers.

Magic mushrooms perform at least as well as the leading antidepressant in new trial

The psychedelic compound found in magic mushrooms may be at least as effective as a leading antidepressant medication in a therapeutic setting, a new study suggests. Researchers compared the therapeutic potential of psilocybin – found in the mushrooms – with a six-week course of the antidepressant escitalopram in 59 people with moderate to severe depression. They found that, while depression scores were reduced in both groups, the reductions occurred more quickly in the psilocybin group and were greater in magnitude. However, they warned that the main comparison between psilocybin and the antidepressant was not statistically significant. They said larger trials with more patients over a longer period are needed to show if the compound can perform as well as, or more effectively than, an established antidepressant.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.